文献速递冠心病

血管内成像对比造影引导复杂PCI:随机试验5年结局

Intravascular Imaging- vs Angiography-Guided Complex PCI: 5-Year Outcomes From a Randomized Trial.
PubMed 文献 · J Am Coll Cardiol · 2026-03-04

该前瞻性多中心开放标签优势试验在韩国纳入1639例复杂冠状动脉病变患者,按2:1随机接受血管内成像引导PCI或造影引导PCI。中位随访5.3年时,成像引导组主要终点(心源性死亡、靶血管相关心肌梗死或临床驱动的靶血管血运重建复合终点)发生率为10.5%,造影引导组为14.9%(HR 0.68;95%CI 0.51-0.91;P=0.009)。

要点

  • 复杂冠脉病变PCI中,血管内成像引导较造影引导降低5年主要复合终点风险。
  • 主要终点绝对风险降低4.4%,需结合个体病变评估成像引导获益。
  • 两组操作相关安全性事件未见明显差异。

核心结论

  • 在复杂冠状动脉病变行PCI的患者中,与造影引导相比,血管内成像引导降低了中位随访5.3年时心源性死亡、靶血管相关心肌梗死或临床驱动靶血管血运重建的复合终点风险。

研究设计与样本

  • 前瞻性多中心开放标签优势试验,在韩国进行, eligible复杂冠状动脉病变患者按2:1随机分配至血管内成像引导PCI组(1092例)或造影引导PCI组(547例),共1639例。

主要发现

  • 中位随访5.3年(Q1-Q3:4.4-6.2年),主要终点在成像引导组109/1092例(10.5%)发生,造影引导组78/547例(14.9%)发生(HR:0.68;95%CI:0.51-0.91;P=0.009)。
  • 心源性死亡或靶血管相关心肌梗死发生在成像引导组78例(7.6%)、造影引导组56例(10.7%)。
  • 临床驱动的靶血管血运重建发生在成像引导组45例(4.4%)、造影引导组32例(6.2%)。
  • 明确支架血栓发生在成像引导组1例(0.1%)、造影引导组4例(0.7%)。
  • 两组间操作相关安全性事件未见明显差异。

临床怎么用

  • 对于复杂冠状动脉病变接受PCI的患者,可考虑采用血管内成像引导以降低长期复合不良事件风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Data regarding long-term outcomes of intravascular imaging-guided percutaneous coronary intervention (PCI) for complex coronary artery lesions, compared with angiography-guided PCI, remain limited. OBJECTIVES: The authors sought to present long-term clinical outcomes of intravascular imaging-guided PCI compared with angiography-guided PCI in patients with complex coronary artery lesions. METHODS: Eligible patients with complex coronary artery lesions were randomly assigned 2:1 to undergo intravascular imaging-guided PCI or angiography-guided PCI in this prospective multicenter open-label superiority trial performed in South Korea. The primary endpoint was a composite of cardiac death, target vessel-related myocardial infarction, or clinically driven target vessel revascularization. RESULTS: A total of 1,639 patients underwent randomization with 1,092 assigned to imaging-guided PCI and 547 assigned to angiography-guided PCI. At a median follow-up of 5.3 years (Q1-Q3: 4.4-6.2 years), the primary endpoint occurred in 109 of 1,092 patients (10.5%) in the intravascular imaging-guided PCI group and 78 of 547 patients (14.9%) in the angiography-guided PCI group (HR: 0.68; 95% CI: 0.51-0.91; P = 0.009). Cardiac death or target vessel-related myocardial infarction occurred in 78 patients (7.6%) in the intravascular imaging-guided PCI group and in 56 patients (10.7%) in the angiography-guided PCI group, clinically driven target vessel revascularization in 45 (4.4%) and 32 (6.2%), and definite stent thrombosis in 1 (0.1%) and 4 (0.7%), respectively. There were no apparent differences in procedure-related safety events between the groups. CONCLUSIONS: In patients with complex coronary artery lesions undergoing PCI, intravascular imaging guidance reduced the risk of a composite of cardiac death, target vessel-related myocardial infarction, or clinically driven target vessel revascularization at median follow-up of 5.3 years, compared to angiography guidance. (Intravascular Imaging- Versus Angiography-Guided Percutaneous Coronary Intervention for Complex Coronary Artery Disease [RENOVATE-COMPLEX-PCI]; NCT03381872).

来源:J Am Coll Cardiol,查看原文。版权归原作者所有。

引用

  1. Lee JM, Kim O, Song YB, et al. Intravascular Imaging- vs Angiography-Guided Complex PCI: 5-Year Outcomes From a Randomized Trial. J Am Coll Cardiol. 2026. PMID: 41778943. doi:10.1016/j.jacc.2026.01.035

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。